期刊文献+

乳腺癌的复发转移病灶需要外科治疗吗? 被引量:1

Does Recurrent or Metastatic Lesions from Breast Cancer Need Surgery?
下载PDF
导出
摘要 复发转移是乳腺癌常见的生物学特性。发生复发转移后,疾病常常不可治愈,主要治疗目的是减轻症状,改善生存质量,尽可能延长生存期。复发转移性乳腺癌被认为是一种全身疾病,局部治疗常不受重视,对于复发转移病灶的手术切除是否需要争议较大。但复发转移性乳腺癌也是一种复杂的异质性疾病,对某些亚组的转移病灶进行手术切除,与单纯全身治疗相比,可能进一步改善预后。 Local recurrence or distant metastasis in breast cancer is common .After recurrence or metastasis ,breast cancer is ultimately incurable ,although treatable .The goal of therapy remains palliative (e .g .,to lessen symptoms ,improve quality of life ,delay disease progression ,and prolong survival) .Metastatic breast cancer is considered a systemic disease , local treatment is often neglected .Surgical resection of recurrent and metastatic lesions is controversial .While metastatic breast cancer is a complex and heterogeneous disease composed of multiple distinct subtypes .Surgical approach to metastatic breast cancer may prolong survival in certain subgroups of patients to a greater extent than systemic treatment alone .
作者 刘鹏熙
出处 《医学与哲学(B)》 2014年第8期12-15,共4页 Medicine & Philosophy(B)
关键词 转移性乳腺癌 外科治疗 metastatic breast cancer surgical treatment
  • 相关文献

参考文献24

  • 1Cardoso F,Costa A, Norton Lvet a1. l st International consensus guidelines for advanced breast cancer (ABC 1) [J]. Breast.2012,2H3) :242-252. 被引量:1
  • 2Petrella F,Radice D.Borri Av et a1. Chest wall resection and reconstruction for locally recurrent breast cancer : From technical aspects to biological assessmentj]], Surgeon.2014,doi: 10. 1016/j. surge. 2014. 03. 001. 被引量:1
  • 3Cardoso F,Harbeck Nv Fallowfield Let a1. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis. treatment and follow-up[J]. Ann Oncol.2012.23(Suppl 7) .vii l l -19. 被引量:1
  • 4Pagani 0, Senkus E,Wood W,et a1. International guidelines for manage- ment of metastatic breast cancer: can metastatic breast cancer be cured? [n.] Nat! Cancer Inst,2010.10Z(7):456-46,3. 被引量:1
  • 5Greaves M. Maley C C. Clonal evolution in cancer[J]. Nat ure , 2012, 481(7381) :306-313. 被引量:1
  • 6Senkus Ev Cardoso F,Pagani O. Time for more optimism in metastatic breast cancer? [n. Cancer Treat Rev,2014,40(Z) :220-228. 被引量:1
  • 7Welter S,Jacobs] .Krbek T,et a1. Pulmonary metastases of breast cancer. When is resection indicated? [J]. Eur J Cardiothorac Surg, 2008,34: 1228- 1234. 被引量:1
  • 8Zegarac M, Nikolic S, Gavrilovic D, et a1. Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer[J]. J BUON ,2013 .18(4) :859-865. 被引量:1
  • 9Abbott D E,Brouquet A. Mittendorf E A. Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome[J]. Surgery, 20] 2,15] (5),710-716. 被引量:1
  • 10Tabouret Ev Mctcllus p,Gon alves Av et al. Assessment of prognostic scores in brain metastases from breast cancer] I']. Neuro Oneal, 2014,16(3) ,421-428,. 被引量:1

二级参考文献34

  • 1Hanahan D, Weinberg RA. Hallmarks of cancer: the next genera- tion [ J ]. Cell,201 l, 144 ( 5 ) :646-674. 被引量:1
  • 2Uchino K, Tateishi R, Shiina S, et al. Hepatocellular carcinoma with extrahepatie metastasis: clinical features and prognostic fac- tors[ J]. Cancer,2011,117 ( 19 ) :4475-4483. 被引量:1
  • 3Ye QH, Qin LX, Forgues M, et al. Predicting hepatitis B virus- positive metastatic hepatoeellular carcinomas using gene expression profiling and supervised machine learning [ J 1. Nat Med,2003,9 (4) :416-423. 被引量:1
  • 4Yamashita T, Ji J, Budhu A, et al. EpCAM-positive hepatocellu- lar carcinoma cells are tumor-initiating cells with stenr/progenitor cell features [ J 3. Gastroenterology,2009,136 ( 3 ) : 1012-1024. 被引量:1
  • 5Budhu A, Forgues M, Ye QH, et al. Prediction of venous metas- tases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenviron- ment [ J 1. Cancer Cell, 2006,10 ( 2 ) :99 - 111. 被引量:1
  • 6. Malanchi I, Santamaria-Martinez A, Susanto E, et al. Interactions between cancer stem ceils and their niche govern metastatic coloni- zation[J]. Nature,2011,481(7379) :85-89. 被引量:1
  • 7Greaves M, Maley CC. Clonal evolution in cancer[ Jl. Nature, 2012,481 (7381) :306-313. 被引量:1
  • 8Liu L, Zhu XD, Wang WQ, et al. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced meta- static potential and poor prognosis[ J. Clin Cancer Res,2010,16 (10) :2740-2750. 被引量:1
  • 9Zhang W, Sun HC, Wang WQ, et al. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice [ J 1. Gastroen- terology ,2012,143 ( 6 ) : 1641-1649. 被引量:1
  • 10Zhang QB, Sun HC, Zhang KZ, et al. Suppression of natural kil- ler cells by sorafenib contributes to prometastatie effects in hepato- cellular carcinoma[J]. PLoS One,2013,8(2) :e55945. 被引量:1

共引文献10

同被引文献9

  • 1Fisher B, Anderson S, Bryant J, et al. Twenty-year follow up of a ran domized trial comparing total masteetomy,lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer[J]. N Engl J Med,2002,347(16) : 1233- 1241. 被引量:1
  • 2Khan S A,Stewart A K, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer?[J]. Surgery, 2002, 132,620-626. 被引量:1
  • 3Cardoso F, Harbeck N, Fallowfield L, et al. Locally recurrent or meta static breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol,2012,23 (Suppl 7) : 11- 19. 被引量:1
  • 4Cardoso F,Costa A,Norton L,et al. 1st International consensus guidelines for advanced breast cancer (ABC1) [J]. Breast,2012,21(3) :242-252. 被引量:1
  • 5Bergenfeldt M,Jensen B V, Skjoldbye B, et al. Liver resection and local ablation of breast cancer liver metastases:a systematic review[J].EurJ SurgOncol,2011,37(7):549 -557. 被引量:1
  • 6Friedel G, Pastorino U, Ginsbcrg R J, et al. Results of lung metasta- sectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases[J]. Eur J Cardiothorac Surg,2002,22(3):335- 344. 被引量:1
  • 7张超杰.乳腺癌诊治过程中的多学科协作[J].医学与哲学(B),2009,30(8):4-5. 被引量:10
  • 8中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2013版)[J].中国癌症杂志,2013,23(8):637-693. 被引量:494
  • 9宋三泰.晚期乳腺癌如何选择内外科治疗[J].医学与哲学(B),2014,35(8):10-11. 被引量:4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部